Nanochon secured $4.1M in funding to launch first-in-human trials for its 3D-printed knee implant. T...

Nanochon secured $4.1M in funding to launch first-in-human trials for its 3D-printed knee implant. The Chondrograft technology uses a regenerative scaffold to regrow tissue, moving orthopedics beyond permanent metal parts. This Phase I study with 10 patients marks a systemic shift toward bio-integrative additive manufacturing. This solution could eliminate the need for total knee replacements in younger patients. 🚀🦴 #AdditiveManufacturing #3DPrinting #MedTech #Nanochon